DiaMedica Therapeutics Inc. (DMAC) Earnings
|
Expand Research on DMAC
| Next EPS Date | 8/12/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +5.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/26  |
Q425 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 | Q325 | -$0.17 | -$0.17 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.18 | -$0.19 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.18 | -$0.20 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 3/17/25 |
Q424 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/24 | Q324 | -$0.15 | -$0.16 | +$0.01 | N/A | N/A | N/A | | | Details |
